Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $186,165 - $223,261
-1,346 Reduced 14.54%
7,913 $1.28 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $210,038 - $240,900
-1,565 Reduced 14.46%
9,259 $1.24 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $633,052 - $804,816
-4,600 Reduced 29.82%
10,824 $1.55 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $2.21 Million - $2.74 Million
-16,725 Reduced 52.02%
15,424 $2.5 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $1.63 Million - $2.07 Million
-15,216 Reduced 32.12%
32,149 $4.35 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $1.44 Million - $1.63 Million
13,506 Added 39.89%
47,365 $5.11 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $469,973 - $523,577
-4,467 Reduced 11.66%
33,859 $3.81 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $709,041 - $780,569
6,931 Added 22.08%
38,326 $4.15 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $423,216 - $571,386
5,258 Added 20.12%
31,395 $3.36 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $625,596 - $734,244
7,282 Added 38.62%
26,137 $2.29 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $1.2 Million - $1.83 Million
-18,680 Closed
0 $0
Q4 2019

Jan 23, 2020

SELL
$72.13 - $90.25 $1.17 Million - $1.47 Million
-16,240 Reduced 46.51%
18,680 $1.65 Million
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $322,772 - $388,065
5,125 Added 17.2%
34,920 $2.64 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $3,942 - $5,038
-60 Reduced 0.2%
29,795 $2.17 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $98,739 - $116,211
-1,280 Reduced 4.11%
29,855 $2.41 Million
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $107,822 - $132,973
1,385 Added 4.66%
31,135 $2.87 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $38,231 - $42,501
-430 Reduced 1.42%
29,750 $2.81 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $49,379 - $58,426
-550 Reduced 1.79%
30,180 $2.8 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $74,528 - $99,800
-810 Reduced 2.57%
30,730 $2.91 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $40,302 - $44,194
-450 Reduced 1.41%
31,540 $3.05 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $2.23 Million - $2.85 Million
31,990
31,990 $2.84 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.